Akalu et al. report new and long-term follow-up cases of human TBK1 deficiency, revealing that, beyond systemic autoinflammation, affected individuals are also vulnerable to severe viral encephalitis. Their findings highlight the dual nature of TBK1 deficiency-combining autoinflammatory disease with impaired antiviral defense-and emphasize the need for antiviral vigilance in care.
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.